Navigation Links
Sartolab P 20 Disposable Pressure Filter, 0.2 m, sterile, single packed from Sartorius AG

ProductsSartolab P 20 Disposable Pressure Filter, 0.2 m, sterile, single packed from Sartorius AG
Company Sartorius AG
Item Sartolab P 20 Disposable Pressure Filter, 0.2 m, sterile, single packed
Price 
Description Sartolab P20 and Sartolab P20 plus for Reliable Sterile Filtration of Tissue Culture Solutions

Ready-to-use units which, attached to a membrane pump or tube pump, quickly and reliably sterilize 100 ml to 5 liter of media and aqueous solutions.

The combination of a large filtration area (20 cm2) and an automatic de-aeration ensures high flow rates and optimal total throughputs. Automatic venting of any trapped air through the PTFE membraneprotected vent ports ensures that the entire filter surface is used for effective filtration.

Sartolab P20 units have an extraordinarily favourable price-performance ratio. Often, the total filterable volume can even be doubled due to an integrated binder-free glass fibre prefilter.

Info Sartorius AGSartorius AG
Weender Landstrasse 94-108
D-37075 Goettingen, Germany
Phone: +49.551.308.0
Fax: +49.551.308.3289

Sartorius North America, Inc.
Biolab - Biotechnology Division
131 Heartland Blvd.
Edgewood, NY 11717
USA
Toll-free: 877-452-2345
Fax: 631-253-5460


Customer Service: +49.551.308.0
Fax Number: +49.551.308.3289
Web Site: http://www.sartorius.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Large Disposable Staining Trays. from PGC Scientifics
2. Disposable Staining Tray for Western Blots from PGC Scientifics
3. Disposable Tips for OneTouch Plus from The Gel Company
4. Disposable Cuvettes, 1,000/pkg from Promega
5. Noninvasive Blood Pressure Software from IITC Life Science
6. Spacer for Miniature FRENCH Pressure Cell from Thermo Scientific
7. Miniature FRENCH Pressure Cell from Thermo Scientific
8. Perfusion Pressure Kit - 8 channel from AutoMate Scientific, Inc
9. Helios Gene Gun Low-Pressure System, 220-240 V from Bio-Rad
10. Helios Gene Gun Low-Pressure System, 100-120 V from Bio-Rad
11. High Pressure Dual Piston Analytical Pump from Cecil Instruments Ltd.
Request Info...
IRF7 Immunogen: Synthetic peptide corresponding to residues E(463) G T Q R E G V S S L D S S S(477) of human IRF7. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Rabbit polyclonal to TetR ( Abpromise for all tested applications). Antigen: Synthetic peptide: AQKLGVEQPTLYWHVKNKR, corresponding to amino acids 31 - 49 of TetR...
Peptide-affinity Purified Polyclonal Antibody to Histamine H2 Receptor...
Biology Products:
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/11/2015)... 11, 2015 According ... Control Market by Product (Cards and Readers, Biometrics, Controllers, ... Government, Industrial, Healthcare, Education) and By Geography - Global Forecast and ... the Access Control Market is expected to ... a CAGR of 10.6% between 2014 and ...
(Date:2/5/2015)... TRIANGLE PARK, N.C. , Feb. 5, 2015 /PRNewswire/ ... a specialist logistics company and has launched a new ... only Clinical Logistics Organization (CLO).  The new campaign focuses ... emphasis on patient, protocol and shipments. The ... First , aligns Marken,s priorities with its client,s ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... in the November 2008 issue of BioScience ... an Era of Genomics and Proteomics. David Emerson, Liane ... genomics and proteomics are changing techniques used for identifying ... levels of discrimination, but standards for their use must ...
... known that it,s possible for one gene to produce slightly ... certain sequences from the messenger RNA. Now, an MIT team ... both far more prevalent and varies more between tissues than ... 94 percent, generate more than one form of their protein ...
... to immune system cells called T-lymphocytes that target a ... fight a form of childhood cancer called neuroblastoma, said ... Hospital in a report that appears online today in ... a way to convert a naturally occurring problem into ...
Cached Biology News:BioScience tip sheet, November 2008 2Human genes sing different tunes in different tissues 2A double-barreled immune cell approach for neuroblastoma 2
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Global Biologics and Biosimilars Industry ... , The Global Biologics and Biosimilars ... study on the current state of the biologics ... a basic overview of the industry including definitions, ...
(Date:3/4/2015)... , March 4, 2015 AcelRx ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... results after market close on Monday, March 9th, ... call at 4:30 p.m. Eastern Time (1:30 p.m. ...
(Date:3/4/2015)... , March 4, 2015 ... Paris in December 2011, ,SARAH, ... yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma ... late 2016.   SARAH, a large French ... (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding ...
(Date:3/3/2015)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... Miami, FL on March 10, 2015 at ... Chief Financial Officer, will provide a corporate overview. ... Halozyme,s corporate website at www.halozyme.com , and a recording ... To access the live webcast, please log on to Halozyme,s ...
Breaking Biology Technology:Global Biologics and Biosimilars Industry Report 2015-2020 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2